Hospice News
JANUARY 30, 2024
billion by 2027, up from $2 billion in 2020. In the United States, the Food and Drug Administration (FDA) in 2018 designated psilocybin as a “breakthrough therapy” for major depressive disorder, which paved the way for expanded clinical trials. The authors cited projections that the U.S. market for those substances would reach $10.75
Hospice News
JULY 21, 2022
A number of states have “Right to Try” laws on their books, and a federal law was instituted in 2018. billion industry by 2027, Forbes reported last July. “As The legislation, dubbed the Right to Try Clarification Act, seeks to elucidate the applicability of existing law as it relates to patients receiving end-of-life care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
JANUARY 10, 2023
In the United States, the Food and Drug Administration (FDA) in 2018 designated psilocybin as a “breakthrough therapy” for major depressive disorder, which paved the way for expanded clinical trials. billion by 2027, up from $2 billion in 2020. The authors cited projections that the U.S. market for those substances would reach $10.75
Hospice News
MAY 10, 2022
The state’s 2018 utilization rate was 46.1% More than 20% of the state’s population will be Medicare eligible by 2027. The First Call asset in that same 12-month period also saw EBITDA rise 113% to $378,000. Pre-acquisition, this was $177,000. . California markets are receiving a lot of attention in the hospice space in recent years.
The Productive Home Health Nurse
AUGUST 28, 2021
And outrageously in 2018, the U.S. billion in home health expenditures by 2027. To place quantities to all of this text, the number of agencies providing home health care in the United States grew from 8,314 in 2005 to 12,613 in 2013 with Medicare expenditures for home health care services alone nearly doubling from 9.7
Expert insights. Personalized for you.
191 
Let's personalize your content